Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1322 issues

UnitedHealthcare's Coverage Criteria for Tagrisso (osimertinib) in Pennsylvania: What Counts as "Medically Necessary"?

Answer Box: Getting Tagrisso Covered by UnitedHealthcare in Pennsylvania To get Tagrisso (osimertinib) covered by UnitedHealthcare in Pennsylvania, you need: documented EGFR mutation (exon 19 deletion or L858R), confirmed NSCLC diagnosis, and prior authorization approval. Submit through the UHC Provider Portal with pathology reports and staging documentation. If denied, Pennsylvania&
5 min read

How to Get Stelara (Ustekinumab) Covered by UnitedHealthcare in Illinois: Complete 2025 Guide to Prior Authorization, Appeals, and Biosimilar Requirements

Answer Box: Getting Stelara Covered by UnitedHealthcare in Illinois UnitedHealthcare requires prior authorization for Stelara (ustekinumab) in Illinois, with most commercial plans now requiring biosimilar trials first. As of 2025, brand Stelara is non-formulary; patients must try Steqeyma or Yesintek unless documenting allergy/intolerance or clinical failure after 6+ weeks
6 min read

How to Get Zokinvy (lonafarnib) Covered by UnitedHealthcare in Virginia: Complete PA Guide with Appeal Scripts

Answer Box: Getting Zokinvy Covered by UnitedHealthcare in Virginia Zokinvy (lonafarnib) requires prior authorization from UnitedHealthcare and is typically non-formulary, requiring a coverage exception. The fastest path: 1) Submit PA through the UHC Provider Portal with genetic confirmation of HGPS/progeroid laminopathy, 2) Include medical necessity letter citing FDA approval
7 min read

How to Get Zokinvy (lonafarnib) Covered by UnitedHealthcare in New York: Complete Appeal Guide

Quick Answer: Getting Zokinvy Covered by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for Zokinvy (lonafarnib) with specific genetic testing requirements. For HGPS patients, you need confirmed diagnosis only. For progeroid laminopathies, you must document heterozygous LMNA mutation with progerin-like protein accumulation OR homozygous/compound heterozygous ZMPSTE24 mutations. Submit
6 min read

Renewing Hetlioz (Tasimelteon) Approval with UnitedHealthcare in New York: Complete 2025 Timeline and Documentation Guide

Answer Box: Hetlioz Renewal with UnitedHealthcare in New York UnitedHealthcare requires annual prior authorization renewal for Hetlioz (tasimelteon), with documentation of positive clinical response. Submit renewal 30 days before expiration via the UnitedHealthcare Provider Portal with updated sleep diaries showing continued benefit. If denied, file internal appeal within 180 days,
5 min read

How to Get StrataGraft Covered by UnitedHealthcare in New York: Prior Authorization Guide with Appeals Process and Documentation Requirements

Quick Answer: Getting StrataGraft Approved by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for StrataGraft (allogeneic cultured keratinocytes & fibroblasts in murine collagen-dsat) under the medical benefit, not pharmacy. Submit via the UHC Provider Portal with burn depth documentation, TBSA calculations, and proof of failed standard therapies. Standard decisions
7 min read

How to Get Breyanzi (lisocabtagene maraleucel) Covered by UnitedHealthcare in Texas: Renewal Guide, Appeals Process & Timeline

Answer Box: Renewing Breyanzi Coverage with UnitedHealthcare in Texas Breyanzi (lisocabtagene maraleucel) renewals with UnitedHealthcare typically require reauthorization every 12 months with documented clinical response evidence. Start the renewal process 60-90 days before expiration by gathering recent labs, imaging showing disease control, and updated performance status documentation. If denied, you
5 min read

Do You Qualify for Aldurazyme (Laronidase) Coverage by UnitedHealthcare in Michigan? Decision Tree & Next Steps

Answer Box: Getting Aldurazyme Covered by UnitedHealthcare in Michigan UnitedHealthcare requires prior authorization for Aldurazyme (laronidase) with confirmed MPS I diagnosis via enzymatic/genetic testing plus specialist attestation. The fastest approval path: (1) Submit PA via UHC Provider Portal with complete diagnostic documentation, (2) Include baseline assessments and monitoring plan,
5 min read